Sartorius Sted BIO
Sartorius Sted BIO
0,47 %
148,40 EUR
0,70
Kurs
148,40
Hög
149,10
Förändring
0,47 %
Låg
146,80
Uppdaterad
17:40:00
Öppen
147,30
Factsheet for Sartorius Sted BIO
Company Profile
Description
Sartorius Stedim Biotech SA supplies pharmaceuticals and laboratory equipment. Sartorius AG owns a majority stake in the firm. The firm operates in two divisions: bioprocess solutions, and lab products and services. The bioprocess solutions business contributes the majority of revenue and provides solutions for the biopharmaceutical industry. Its products include process control tools, fluid management systems, bioreactors, fermenters, and filtration and purification products. The lab products segment supplies laboratory instruments and consumables, including balances, quality-control products, pipettes, cell cultivation tools, and laboratory water purification systems. Sartorius Stedim Biotech generates the largest proportion of its revenue in the Europe, Middle East, and Africa region.
Key Stats
Website: http://www.sartorius-stedim.com
Headquarter country: France
Employees: 3 156
Market Cap (at close 19-07-2019): EUR 14B
Fiscal Year Ends: december
Stats

Stats 2018 2017 2016 2015 2014
Price/Earnings 46,50 35,30 38,90 61,00 37,40
Forward Price/Earnings 31,30 27,90 27,20 32,90 23,60
Price/Free Cash Flow 145,60 76,20 85,00 67,30 33,20
Return on Assets 14,00 12,40 13,60 12,00 8,20
Return on Equity 21,80 19,80 22,00 20,10 14,30
Return on Invested Capital 19,20 17,40 19,40 17,20 11,90
Dividend


Dividend/Share:0,50
Ex. Dividend Date:2018-12-31
Trailing Dividend Yield:0,39
Payout Ratio:20,35
Date Currency Amount
2018-06-30 EUR 0,46
2016-06-30 EUR 0,33
2015-06-30 EUR 0,22
2014-06-30 EUR 0,20
2013-06-30 EUR 0,18
Income Statement

Revenue 2018 2017 2016 2015 2014
Total Revenue 1 212,15 1 081,03 1 051,61 884,33 683,52
Gross Profit 0,63 0,55 0,53 0,45 0,34
Gross Margin % 51,94% 51,32% 50,10% 51,09% 49,98%
Operating Expenses 2018 2017 2016 2015 2014
EBITDA 349,00 276,00 262,00 214,00 147,00
Net income 208,00 161,00 154,00 118,00 72,00
Basic Earnings Per Share 2,26 1,75 1,67 1,28 0,79
Operating Income 0,29 0,25 0,24 0,20 0,12
Operating Margin % 23,72% 23,25% 22,99% 22,35% 17,93%
Cash Flow

Cash Flow 2018 2017 2016 2015 2014
Operating Cash Flow 227,00 175,00 157,00 143,00 111,00
Capital Expenditures -177,00 -127,00 -80,00 -53,00 -47,00
Free Cash Flow 51,00 48,00 77,00 90,00 64,00
Balance Sheet

Assets 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Current Assets 552,53 490,85 431,73 350,83 276,17 258,51
Long Term Assets 1 018,93 913,06 764,12 715,31 630,59 612,72
Total Assets 1 571,46 1 403,91 1 195,85 1 066,14 906,76 871,23
Liabilities 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Total Current Liabilities 381,98 350,44 284,36 272,69 229,58 154,38
Long Term Liabilities 181,43 153,48 152,01
Total Liabilities 531,88 437,84 424,70
Equity 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Retained Earnings 786,44 622,07 508,40 390,84 282,07 189,15
Treasury Stock
Total Stockholder Equity 1 036,40 872,03 758,01 641,44 532,48 478,34
Net Tangible Assets 474,21 313,08 269,21 161,13 106,12 52,71